Ekkehard Schütz
Chief Tech/Sci/R&D Officer chez ONCOCYTE CORPORATION
Profil
Dr. Ekkehard Schütz is a Chief Science Officer at OncoCyte Corp.
and a Chief Executive Officer & Chief Medical Officer at Chronix Biomedical, Inc. He received his doctorate degree from the University of Gottingen.
Postes actifs de Ekkehard Schütz
Sociétés | Poste | Début |
---|---|---|
ONCOCYTE CORPORATION | Chief Tech/Sci/R&D Officer | 01/04/2021 |
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | Chief Executive Officer | - |
Formation de Ekkehard Schütz
University of Gottingen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ONCOCYTE CORPORATION | Health Technology |
Entreprise privées | 1 |
---|---|
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | Health Technology |